Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
central nervous system disorders
|
| gptkbp:foundedBy |
gptkb:SK_Group
|
| gptkbp:headquartersLocation |
gptkb:Paramus,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
SK Life Science, Inc.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:cenobamate
|
| gptkbp:parentCompany |
gptkb:SK_Biopharmaceuticals
|
| gptkbp:subsidiary |
gptkb:SK_Biopharmaceuticals
|
| gptkbp:website |
https://www.sklifescienceinc.com/
|
| gptkbp:bfsParent |
gptkb:SK_Biopharmaceuticals
|
| gptkbp:bfsLayer |
6
|